Results 201 to 210 of about 36,039 (270)

Case Report: Qizhi Yishen Capsule-induced bone marrow granulomas and severe myelosuppression. [PDF]

Front Allergy
Xie P, Zhang Y, Jiang J, Chen C, Wang Y, Liu L.   +5 more
europepmc   +1 more source

Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model. [PDF]

BMC Med Imaging
Sun C, Chu A, Liu S, Song R, Yang J, Liu X, Gan L, Wang Y, Liu Z, Wang X, Li M.   +10 more
europepmc   +1 more source

Case Report: Early introduction of anti-GD2 immunotherapy during induction chemotherapy in high-risk neuroblastoma: two pediatric cases. [PDF]

Front Oncol
Hu T, Li J, He L, Zhang X, Xu J, Li T, Zhou L.   +6 more
europepmc   +1 more source

Multidisciplinary management of pregnancy-associated breast cancer: a clinical pharmacy perspective on chemotherapy and perinatal outcomes. [PDF]

Front Oncol
Liu H, Jin J, Deng Y, Wang X, Zeng T.
europepmc   +1 more source

Refractory thrombocytopenia induced by enzalutamide combined with docetaxel chemotherapy in a metastatic castration-resistant prostate cancer patient with bone marrow metastasis: a case report and literature review. [PDF]

Front Oncol
Chen Y, Liu J.
europepmc   +1 more source

Chemotherapy-Induced Myelosuppression in Patients With gBRCA-m Epithelial Ovarian Cancer: A Retrospective Study. [PDF]

Cancer Med
Hu H, Nie X, Jiang Y, Shi C, Chen X, Zhang W, Wu S, Cheng Y, Zhang L, Jiang Y, Zhou S, Luo C, Yuan L, Cheng W.   +13 more
europepmc   +1 more source

Atypical Vesicular Skin Eruption Following a Low-Dose Methotrexate Dosing Error: A Case Report. [PDF]

Cureus
London MGH, Frasier KM, Werpachowski NK, Scaduto J.   +3 more
europepmc   +1 more source

Fatal 5-Fluorouracil Toxicity With Hyperammonemic Encephalopathy, Lactic Acidosis, and Pneumatosis Intestinalis Despite Uridine Triacetate Rescue: A Case Report. [PDF]

Cureus
Matar H, Sembroski E, Buzard B, Shewmaker J, Blunck JR.   +4 more
europepmc   +1 more source

The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use. [PDF]

Front Pharmacol
Yamaoka K, Kajita S, Kume M, Hirabatake M, Sato Y, Hashida T, Tachikawa R, Muroi N.   +7 more
europepmc   +1 more source

Challenging the Conventional Wisdom Around Doxorubicin in Soft Tissue Sarcoma. [PDF]

JCO Oncol Pract
Stein JN, Woodcock MG, Chen KY.
europepmc   +1 more source